However, CDKN2AIP is upregulated in HD NSCs (Figure S6A, middle panel), which could increase the activity of p14ARF, a gene also upregulated in HD NSCs (see below), and promotes cellular resistance in a FOXO3‐independent manner. This evidence concerns the gene CDKN2A and Huntington disease.